Gandamon, Marivic M.

HRN: 21-73-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2022
CEFUROXIME 1.5GM (VIAL)
08/06/2022
08/13/2022
IV
1.5gms
Q8
Uti, R/o Acute Pancreatitis

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: